Literature DB >> 10905967

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

H E de Melker1, J F Schellekens, S E Neppelenbroek, F R Mooi, H C Rümke, M A Conyn-van Spaendonck.   

Abstract

We analyzed pertussis reporting, death, hospitalization, and serodiagnostic data from 1976 to 1998 to help explain the cause of the 1996 pertussis outbreak in the Netherlands. The unexpected outbreak was detected by an increase in pertussis reporting and by other surveillance methods. In 1996, according to reporting and serologic data, the increase in pertussis incidence among (mostly unvaccinated) children less than 1 year of age was similar to the increase in hospital admissions. Among older (mostly vaccinated) persons, the increase in hospital admissions was relatively small. The increase in pertussis incidence was higher among vaccinated than among unvaccinated persons of all ages. This resulted in lower estimates of vaccine effectiveness. The proportion of pertussis infections resulting in recognizable symptoms may have increased among vaccinated persons because of a mismatch of the vaccine strain and circulating Bordetella pertussis strains. The small immunogenicity profile of the Dutch vaccine may have resulted in greater vulnerability to antigenic changes in B. pertussis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905967      PMCID: PMC2640897          DOI: 10.3201/eid0604.000404

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  23 in total

1.  Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children.

Authors:  Paola Mastrantonio; Patrizia Spigaglia; Hans van Oirschot; Han G J van der Heide; Kees Heuvelman; Paola Stefanelli; Frits R Mooi
Journal:  Microbiology       Date:  1999-08       Impact factor: 2.777

2.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.

Authors:  F R Mooi; Q He; H van Oirschot; J Mertsola
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.

Authors:  D Güriş; P M Strebel; B Bardenheier; M Brennan; R Tachdjian; E Finch; M Wharton; J R Livengood
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

5.  Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population.

Authors:  A D Bentsi-Enchill; S A Halperin; J Scott; K MacIsaac; P Duclos
Journal:  Vaccine       Date:  1997-02       Impact factor: 3.641

6.  Pertussis notifications in Australia, 1991 to 1997.

Authors:  R Andrews; A Herceg; C Roberts
Journal:  Commun Dis Intell       Date:  1997-05-29

7.  Serum IgA antibody to Bordetella pertussis as an indicator of infection.

Authors:  J Nagel; E J Poot-Scholtens
Journal:  J Med Microbiol       Date:  1983-11       Impact factor: 2.472

8.  Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994.

Authors:  D Guris; P M Strebel; R Tachdjian; B Bardenheier; M Wharton; S C Hadler
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

9.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

10.  Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels.

Authors:  J Nagel; S de Graaf; D Schijf-Evers
Journal:  Dev Biol Stand       Date:  1985
View more
  66 in total

1.  Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  K A Gordon; J Fusco; D J Biedenbach; M A Pfaller; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Authors:  Inge H M van Loo; Kees J Heuvelman; Audrey J King; Frits R Mooi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Maternal immunity provides protection against pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s.

Authors:  Leo M Schouls; Han G J van der Heide; Luc Vauterin; Paul Vauterin; Frits R Mooi
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

5.  Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants.

Authors:  Gaëtan Muyldermans; Denis Piérard; Nathalie Hoebrekx; Reza Advani; Shirley Van Amersfoorth; Iris De Schutter; Oriane Soetens; Leo Eeckhout; Anne Malfroot; Sabine Lauwers
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 6.  The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA.

Authors:  Kimberly B Decker; Tamara D James; Scott Stibitz; Deborah M Hinton
Journal:  Microbiology       Date:  2012-05-24       Impact factor: 2.777

7.  Modelling the long-term dynamics of pre-vaccination pertussis.

Authors:  Ganna Rozhnova; Ana Nunes
Journal:  J R Soc Interface       Date:  2012-06-20       Impact factor: 4.118

8.  Update on pertussis and pertussis immunization.

Authors:  Jung Yun Hong
Journal:  Korean J Pediatr       Date:  2010-05-31

9.  Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.

Authors:  Atsuko Kodama; Kazunari Kamachi; Yoshinobu Horiuchi; Toshifumi Konda; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

10.  External quality assessment for molecular detection of Bordetella pertussis in European laboratories.

Authors:  G Muyldermans; O Soetens; M Antoine; S Bruisten; B Vincart; F Doucet-Populaire; N K Fry; P Olcén; J M Scheftel; J M Senterre; A van der Zee; M Riffelmann; D Piérard; S Lauwers
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.